We firmly believe in the potential of predictive medicine, and have recently embarked on an innovative project aimed at developing a machine to produce slides for liquid biopsies.
Tethis has created a nanoparticle deposition facility used for the production of microscopy slides employed in the detection of circulating tumor cells in the blood (ctc).
This instrument is essential for preparing high-quality slides used in the analysis of liquid biopsy samples, such as blood, to diagnose and monitor diseases, particularly cancer.
Clitia
Tethis
The client is an Italian SME specializing in liquid biopsy, a diagnostic technique that promises to revolutionize the management of cancer, detecting it earlier and guiding treatment more effectively.
To ensure accurate results, Tethis commissioned Kaira Engineering to develop the Control Unit to automate the process of nanoparticle deposition on installed substrates. The system can be used with the same nanoparticle deposition technology to process a variety of substrates for other applications.
How it works
The hardware
The formation of nanoparticles in the plant occurs through the generation of high vacuum.
The nanoparticles thus generated, using appropriate mechanical conduits, are directed toward the material to be subjected to deposition.
A rotation unit inside the deposition chamber allows multiple products to be exposed at the same time.
Our contribution
What we did during this project
Design and implementation of an automatic system for controlling the production of diagnostic slides, according to EN61010-1 – Safety of equipment for the Laboratory and IEC61326-1 EMC Testing.
Development and testing of a dedicated Software (c#) with touch operator interface, for assisted or automatic execution of the production process, based on .NET 8.0 and WPF